Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Patients With Pancreatic Cancer and Peritoneal Metastasis

NCT04858009 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT04858009
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04858009 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Patients With Pancreatic Cancer and Peritoneal Metastasis
Lead sponsor
Mayo Clinic
Phase
Phase 2
Overall status
Recruiting
Start date
February 15, 2024
Completion date
July 31, 2029
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic malignant neoplasm in the peritoneum, metastatic pancreatic carcinoma, stage iv pancreatic cancer ajcc v8